Prevalence of catheter-related haemodialysis infections in Hospital Universitario San Rafael, Bogotá, Colombia
PDF (Español (España))
HTML (Español (España))

Supplementary Files

Carta de presentación (Español (España))


Chronic kidney disease

How to Cite

Gómez J, Pimienta L, Pino RF, Hurtado M, Villaveces M. Prevalence of catheter-related haemodialysis infections in Hospital Universitario San Rafael, Bogotá, Colombia. Rev. Colomb. Nefrol. [Internet]. 2017 Nov. 23 [cited 2022 Nov. 26];5(1):17-25. Available from:


Introduction: Catheter-associated infection is an entity with multiple complications, a condition that alters the quality of life of all patients on hemodialysis. The aim was to estimate the prevalence of infection associated with intravascular hemodialysis devices at the San Rafael Clinical University Hospital over a period of two years, as well as to evaluate the associated infectious complications, readmissions and death in the study population.

 Methodology: Cross-sectional study of association in which the totality of hemodialysis patients attended in the institution during 2015 and 2016 was included. The analysis is presented in descriptive terms and associations of demographic variables and other outcomes with infection.

Results: The prevalence of catheter-associated infection was 5.62%. A total of 320 patients were included, 18 with catheter-associated infection. The most common germ was methicillin susceptible Staphylococcus aureus with 61.1% of cases. There is a statistically significant association with septic thrombosis and the need for admission to the ICU (p = 0.0000).
PDF (Español (España))
HTML (Español (España))


1. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. ClinInfectDis. 2009;49(1):1.

2. Böhlke M, Uliano G BF. Hemodialysis catheter-related infection: Prophylaxis, diagnosis and treatment. J Vasc Access. 2015;16(5):347–55.

3. Of OJOS KDIGO (KDIGO) CWG. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. KidneyIntSuppl. 2013;3(1):4.

4. George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C HA. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. Bmj.2006;332(7555):1435–0.

5. Port F EG. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): A cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004;44(5 suppl 2):1–6.

6. Martínez-Castelao A, Górriz-Teruel JL, Bover-Sanjuán J, Segura-de la Morena J, Cebollada J, Escalada J et al. Documento de consenso para la detección y manejo de la enfermedad renal crónica. Aten Primaria Endocrinol y Nutr. 2014;61(9):e25–43. https://doi.org10.1016j.endonu.2014.06.003

7. Barrero L RS V. Protocolo de vigilancia en salud pública: Infecciones asociadas a dispositivos. InstNac Salud, Minist Salud. 2016;volumen ve:3–70.

8. Hoen B, Paul-Dauphin A, Hestin D KM. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9(5):869–76.

9. Lok C, Thumma J, Mccullough K, Gillespie B, Fluck R, Marshall M, Kawanishi H, Robinson B PR. Catheter-relatedinfection and septicemia: impact of seasonality and modifiable practices from the DOPPS. Semin Dyalisis. 2014;27(1):72–7.

10. Taylor G, Gravel D, Johnston L, Embil J, Holton D PS. Incidence of blood stream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control. 2004;32(3):155–60. https://doi.org10.1016/j.ajic.2003.05.007

11. MPS Ministerio de la Protección social. Resolucion 8430/1993 Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación á. Bogotá. 1993.

12. Tokars JI, Miller ER SG. New national surveillance system for hemodialysis-associated infections: Initial results. Am J Infect Control. 2002;30(5):288–95.

13. Tokars JI, Miller ER, Alter MJ AM. National surveillance of dialysis-associated diseases in the United States,1992. ASAIO J. 1999;40(4):1020–31. https://doi.org10.109700002480-199440040-00021

14. Crnich CJ MD. Infections of vascular devices. Cohen J, Powderly WG, editores Infectious Diseases. 2004. p. 629–39.

15. J. F. Infections related to intravascular devices used for infusión therapy. EnfermInfeccMicrobiolClin. 2008;26(3):168–74.
No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.




Download data is not yet available.